StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) shareholders

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

Ownership

Who owns BioCorRx's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Lourdes FelixCEO and CFO, Director843,5782.83%Jan 31, 2025
Louis C. LucidoPresident, Director, 10% owner2,788,2199.37%Jan 31, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Lourdes Felix
CEO and CFO, Director
Dec 31, 2024Award+13,158––843,578
Louis C. Lucido
President, Director, 10% owner
Dec 31, 2024Award+13,158––2,511,940
Louis C. Lucido
President, Director, 10% owner
Dec 31, 2024Award+43,860––2,498,782
Louis C. Lucido
President, Director, 10% owner
Nov 29, 2024Award+55,494––2,454,922
Louis C. Lucido
President, Director, 10% owner
Oct 31, 2024Award+55,556––2,399,428
Louis C. Lucido
President, Director, 10% owner
Oct 14, 2024Award+1,105,218––2,343,872
Lourdes Felix
CEO and CFO, Director
Sep 30, 2024Award+15,625––830,420
Louis C. Lucido
President, Director, 10% owner
Sep 30, 2024Award+52,085––1,223,029
Louis C. Lucido
President, Director, 10% owner
Sep 30, 2024Award+15,625––1,238,654
Louis C. Lucido
President, Director, 10% owner
Aug 30, 2024Award+55,559––1,170,944
Louis C. Lucido
President, Director, 10% owner
Jul 31, 2024Award+32,092––1,115,385
Lourdes Felix
CEO and CFO, Director
Jul 2, 2024Award+500,000––814,795
Louis C. Lucido
President, Director, 10% owner
Jun 28, 2024Award+34,016––622,816
Louis C. Lucido
President, Director, 10% owner
Jun 28, 2024Award+10,204––588,800
Lourdes Felix
CEO and CFO, Director
Jun 28, 2024Award+10,204––90,599
Luisa Ingargiola
Director
Jun 28, 2024Award+10,204––64,191
Louis C. Lucido
President, Director, 10% owner
May 31, 2024Award+22,831––578,596
Louis C. Lucido
President, Director, 10% owner
Apr 30, 2024Award+21,552––555,765
Lourdes Felix
CEO and CFO, Director
Apr 24, 2024Award+224,196––314,795
Louis C. Lucido
President, Director, 10% owner
Apr 24, 2024Other+460,477––1,083,293
Luisa Ingargiola
Director
Mar 28, 2024Award+5,566––53,987
Joseph J. Galligan
Director, 10% owner
Mar 28, 2024Award+5,566––237,858
Lourdes Felix
CEO and CFO, Director
Mar 28, 2024Award+5,566––80,395
Louis C. Lucido
President, Director, 10% owner
Mar 28, 2024Award+18,553––534,213
Louis C. Lucido
President, Director, 10% owner
Mar 28, 2024Award+5,566––515,660
Harsha Murthy
Director
Mar 28, 2024Award+5,566––19,719
Louis C. Lucido
President, Director, 10% owner
Feb 29, 2024Award+16,892––510,094
Louis C. Lucido
President, Director, 10% owner
Jan 31, 2024Award+18,269––493,202
Louis C. Lucido
Interim President, Director, 10% owner
Jan 16, 2024Buy+126$0.70$88474,933
Louis C. Lucido
Interim President, Director, 10% owner
Jan 12, 2024Buy+3,000$0.70$2.10K474,807
Joseph J. Galligan
Director, 10% owner
Jan 2, 2024Award+6,173––232,292
Harsha Murthy
Director
Jan 2, 2024Award+6,173––14,153
Louis C. Lucido
Director, 10% owner
Jan 2, 2024Award+6,173––471,807
Luisa Ingargiola
Director
Jan 2, 2024Award+6,173––48,421
Lourdes Felix
CEO and CFO, Director
Jan 2, 2024Award+6,173––74,829
Joseph J. Galligan
Director, 10% owner
Sep 29, 2023Award+2,858––226,119
Kent Emry
Director
Sep 29, 2023Award+2,858––114,065
Louis C. Lucido
Director, 10% owner
Sep 29, 2023Award+2,858––465,634
Lourdes Felix
CEO and CFO, Director
Sep 29, 2023Award+2,858––68,656
Harsha Murthy
Director
Sep 29, 2023Award+2,858––7,980
Luisa Ingargiola
Director
Sep 29, 2023Award+2,858––42,248
Joseph J. Galligan
Director, 10% owner
Jun 30, 2023Award+2,891––223,261
Lourdes Felix
CEO and CFO, Director
Jun 30, 2023Award+2,891––65,798
Kent Emry
Director
Jun 30, 2023Award+2,891––111,207
Harsha Murthy
Director
Jun 30, 2023Award+2,891––5,122
Louis C. Lucido
Director, 10% owner
Jun 30, 2023Award+2,891––462,776
Luisa Ingargiola
Director
Jun 30, 2023Award+2,891––39,390
Louis C. Lucido
Director, 10% owner
Apr 3, 2023Other+183,606––459,885
Louis C. Lucido
Director, 10% owner
Apr 3, 2023Buy+171,296$1.75$299.77K276,279
Joseph J. Galligan
Director, 10% owner
Mar 31, 2023Award+2,824––220,370
Kent Emry
Director
Mar 31, 2023Award+2,824––108,316
Louis C. Lucido
Director, 10% owner
Mar 31, 2023Award+2,824––104,983
Harsha Murthy
Director
Mar 31, 2023Award+2,231––2,231
Lourdes Felix
CEO and CFO, Director
Mar 31, 2023Award+2,824––62,907
Luisa Ingargiola
Director
Mar 31, 2023Award+2,824––36,499
Joseph J. Galligan
Director, 10% owner
Mar 29, 2023Buy+171,296$1.75$299.77K217,546
Louis C. Lucido
Director, 10% owner
Jan 30, 2023Buy+300$1.39$417102,059
Louis C. Lucido
Director, 10% owner
Jan 30, 2023Buy+100$1.37$137102,159
Louis C. Lucido
Director, 10% owner
Jan 26, 2023Buy+500$1.29$645101,759
Louis C. Lucido
Director, 10% owner
Jan 24, 2023Buy+200$1.20$240101,259

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
22.2
At 0M shares a day
Change since last report
-0.2%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioCorRx's stock actually held short. Settlement fails (shares not delivered on time) peaked at 25 shares on Sep 17, 2026 over the last 90 days.

See a number that looks wrong?